FFCP PHASE1:Mm9::chr5:53448964..53448972,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=20531|HGNC=|MCL_coexpression_id=37|UniProt=E9Q0Z3|association_with_transcript=-422bp_to_ENSMUST00000168667_5end|description=CAGE_peak_4_at_Slc34a2_5end|id=chr5:53448964..53448972,+|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0001911!2.05e-16!2;UBERON:0000076!2.05e-16!2;UBERON:0005333!2.05e-16!2;UBERON:0008425!2.05e-16!2;UBERON:0005311!2.05e-16!2;UBERON:0005153!1.69e-15!17;UBERON:0005157!4.84e-13!27;UBERON:0002048!1.31e-08!14;UBERON:0000117!1.31e-08!14;UBERON:0000171!1.31e-08!14;UBERON:0000170!1.31e-08!14;UBERON:0005597!1.31e-08!14;UBERON:0000118!1.31e-08!14;UBERON:0005178!3.95e-07!17;UBERON:0005181!3.95e-07!17;UBERON:0002224!3.95e-07!17;UBERON:0000915!3.95e-07!17;UBERON:0008947!3.95e-07!17;UBERON:0003258!3.95e-07!17|ontology_enrichment_uberon_v019_2=UBERON:0001911,1.87e-86,2;UBERON:0000076,1.87e-86,2;UBERON:0005333,1.87e-86,2;UBERON:0008425,1.87e-86,2;UBERON:0005311,1.87e-86,2;UBERON:0003100,5.67e-17,11;UBERON:0005085,1.42e-14,13;UBERON:0005153,1.86e-11,17;UBERON:0005157,6.23e-10,20;UBERON:0002365,3.41e-08,25;UBERON:0002330,3.41e-08,25|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.384218305321555,0,0,0,0,0,0.122490799214954,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.372140947668503,0,0,0,0,0.369506380333209,0,0,0,0,0,0,0,0,0.221464689648775,0.159454768657487,0,0.172684981865896,0,0,0,57.5364199432272,2.48343071674259,0,0,0,0,0.315508219416257,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.203319467126849,0,0,0,0,0.0826534557253359,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p4@Slc34a2}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=entrezgene:20531 | |||
|HGNC= | |||
|MCL_coexpression_id=37 | |||
|TSSclassifier=NA | |||
|UniProt=uniprot:E9Q0Z3 | |||
|association_with_transcript=-422bp_to_ENSMUST00000168667_5end | |||
|cluster_id=chr5:53448964..53448972,+ | |||
|description=CAGE_peak_4_at_Slc34a2_5end | |||
|id=chr5:53448964..53448972,+ | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0001911!2.05e-16!2;UBERON:0000076!2.05e-16!2;UBERON:0005333!2.05e-16!2;UBERON:0008425!2.05e-16!2;UBERON:0005311!2.05e-16!2;UBERON:0005153!1.69e-15!17;UBERON:0005157!4.84e-13!27;UBERON:0002048!1.31e-08!14;UBERON:0000117!1.31e-08!14;UBERON:0000171!1.31e-08!14;UBERON:0000170!1.31e-08!14;UBERON:0005597!1.31e-08!14;UBERON:0000118!1.31e-08!14;UBERON:0005178!3.95e-07!17;UBERON:0005181!3.95e-07!17;UBERON:0002224!3.95e-07!17;UBERON:0000915!3.95e-07!17;UBERON:0008947!3.95e-07!17;UBERON:0003258!3.95e-07!17 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001911,1.87e-86,2;UBERON:0000076,1.87e-86,2;UBERON:0005333,1.87e-86,2;UBERON:0008425,1.87e-86,2;UBERON:0005311,1.87e-86,2;UBERON:0003100,5.67e-17,11;UBERON:0005085,1.42e-14,13;UBERON:0005153,1.86e-11,17;UBERON:0005157,6.23e-10,20;UBERON:0002365,3.41e-08,25;UBERON:0002330,3.41e-08,25 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.384218305321555,0,0,0,0,0,0.122490799214954,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.372140947668503,0,0,0,0,0.369506380333209,0,0,0,0,0,0,0,0,0.221464689648775,0.159454768657487,0,0.172684981865896,0,0,0,57.5364199432272,2.48343071674259,0,0,0,0,0.315508219416257,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.203319467126849,0,0,0,0,0.0826534557253359,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p4@Slc34a2 | |||
}} |
Revision as of 11:18, 4 August 2015
Short description: | p4@Slc34a2 |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_4_at_Slc34a2_5end |
Coexpression cluster: | MCL_coexpression_mm9:37 |
Association with transcript: | -422bp_to_ENSMUST00000168667_5end |
EntrezGene: | 20531 |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
mammary gland | 1.87e-86 | 2 |
external ectoderm | 1.87e-86 | 2 |
mammary bud | 1.87e-86 | 2 |
mammary ridge | 1.87e-86 | 2 |
mammary placode | 1.87e-86 | 2 |
female organism | 5.67e-17 | 11 |
ectodermal placode | 1.42e-14 | 13 |
epithelial bud | 1.86e-11 | 17 |
epithelial fold | 6.23e-10 | 20 |
exocrine gland | 3.41e-08 | 25 |
exocrine system | 3.41e-08 | 25 |